SBI Securities Co. Ltd. bought a new stake in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 9,802 shares of the company’s stock, valued at approximately $882,000.
Several other hedge funds have also made changes to their positions in the company. Jones Financial Companies Lllp lifted its stake in DocuSign by 41.4% in the fourth quarter. Jones Financial Companies Lllp now owns 20,486 shares of the company’s stock worth $1,842,000 after acquiring an additional 6,001 shares during the period. Smartleaf Asset Management LLC raised its holdings in shares of DocuSign by 781.6% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,204 shares of the company’s stock valued at $202,000 after purchasing an additional 1,954 shares in the last quarter. US Bancorp DE lifted its position in shares of DocuSign by 10.7% in the 4th quarter. US Bancorp DE now owns 3,942 shares of the company’s stock worth $355,000 after purchasing an additional 381 shares during the period. Mutual of America Capital Management LLC bought a new position in shares of DocuSign during the fourth quarter valued at approximately $9,643,000. Finally, Verus Capital Partners LLC purchased a new position in DocuSign during the fourth quarter valued at approximately $201,000. 77.64% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on DOCU shares. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a report on Tuesday, February 4th. JPMorgan Chase & Co. upped their price objective on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research note on Tuesday, December 3rd. Morgan Stanley lifted their target price on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research note on Friday, December 6th. JMP Securities reissued a “market outperform” rating and set a $124.00 price target on shares of DocuSign in a research report on Tuesday, January 7th. Finally, UBS Group raised their price target on shares of DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a report on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $92.45.
Insider Buying and Selling at DocuSign
In other DocuSign news, CEO Allan C. Thygesen sold 40,000 shares of DocuSign stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $90.04, for a total transaction of $3,601,600.00. Following the completion of the sale, the chief executive officer now directly owns 156,050 shares in the company, valued at approximately $14,050,742. The trade was a 20.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction on Monday, December 16th. The shares were sold at an average price of $94.60, for a total transaction of $50,516.40. Following the completion of the sale, the director now directly owns 7,736 shares in the company, valued at $731,825.60. This trade represents a 6.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 686,010 shares of company stock worth $66,102,694. 1.66% of the stock is currently owned by insiders.
DocuSign Trading Down 1.8 %
NASDAQ:DOCU opened at $81.70 on Tuesday. The company has a market capitalization of $16.51 billion, a P/E ratio of 16.85, a PEG ratio of 6.94 and a beta of 0.89. DocuSign, Inc. has a 12 month low of $48.70 and a 12 month high of $107.86. The firm has a fifty day simple moving average of $90.14 and a 200-day simple moving average of $78.07.
DocuSign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also
- Five stocks we like better than DocuSign
- Market Cap Calculator: How to Calculate Market Cap
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Why Invest in High-Yield Dividend Stocks?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.